Assessing antimicrobial consumption in public and private sectors within the Costa Rican health system: current status and future directions
José Pablo Díaz-Madriz, Carolina Rojas-Chinchilla, Esteban Zavaleta-Monestel, Shing Mi Ching-Fung, Hugo Marin-Piva, Gustavo H Marin, Lucia Giangreco · 2024
Read Assessing antimicrobial consumption in public and private sectors within the Costa Rican health system: current status and future directions by José Pablo Díaz-Madriz, Carolina Rojas-Chinchilla, Esteban Zavaleta-Monestel, Shing Mi Ching-Fung, Hugo Marin-Piva, Gustavo H Marin, Lucia Giangreco (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11575047.txt.
Description
Díaz-Madriz and co-authors take Costa Rica's antibiotic pulse for 2019, the baseline year for resistance policy. Following World Health Organization method, they merged public-sector dispensing records with private-sector sales data and converted both into standard daily doses per thousand residents. National use came to 14.32 such doses a day.
Penicillins led overall and in public care, where cautious Access-class drugs made up 83 percent of use. Private care told another story: macrolides led, and 61 percent of private antibiotics were Watch-class drugs, the ones stewardship guards most. The authors urge joint public-private surveillance and tighter rules where the Watch share runs high, offering their method to the region.
Catalog record
| CREATOR | José Pablo Díaz-Madriz, Carolina Rojas-Chinchilla, Esteban Zavaleta-Monestel, Shing Mi Ching-Fung, Hugo Marin-Piva, Gustavo H Marin, Lucia Giangreco |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 45 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |